Nexium Case Begins To Define Contours Of Actavis Decision
Recently, a federal judge in Massachusetts largely denied a series of motions seeking dismissal of various "pay-for-delay" claims brought by direct and indirect purchasers involving AstraZeneca PLC's acid reflux drug Nexium....To view the full article, register now.
Already a subscriber? Click here to view full article